Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)
PaperCitations, authors & open-access status
Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 97 citations, 2021 year and gold oa status.
97
Citations
2021
Year
gold
OA Status